Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)
Clinical trial NCT06226662 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06226662
- Sponsor
- NovelMed Therapeutics
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-10-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.